In Vitro Cytotoxic Potential and Apoptotic Activity of Bufadienolide-rich Fraction from Leaves of Kalanchoe mortagei against Human HeLa Cancer Cells
Objective: The aim of this study was to evaluate the chemical composition as well as to assess the cytotoxicity of Kalanchoe mortagei. Materials and Methods: The plant chemical composition was determined by HPLC coupled to mass spectrometer. The cytotoxicity of methanol extract from leavesÂ of Kalanchoe mortagei (KB) was carried out against human cervical cancer cells (HeLa), breast cancer (MCF-7), brain cancer (U373),Â breast adenocarcinoma (MDA-MB-231) andÂ umbilical vein endothelial cells (HUVEC) by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.Â KB was added at various concentrations of 6.25, 12.5, 25, 50, 100 and 200 Âµg/ml. In addtion, cell morphological changesÂ and apoptosis were also evaluated. Results: A bufadienolides-rich fraction (BRF) containing nine bufadienolides was identified by HPLC/MS whichÂ to significantly reduce proliferation of HeLa cells. Bufadienolides identified included 3Î²-Acetate Hellebrigenin, Bufotalinin, 19-Oxo-bufalin, Hellebrigenin, Monohydroxy-bufotalin, 19-oxo-desacetylcinobufagin, 1Î²-Hidroxybufalin, Bufalin, and 3-Dehydroxy cinobufagin. Discussion & Conclusion:Â K. mortagei contains bufadienolides with specific cytotoxic activity on cancer cells without affect to normal cells, suggesting that its consumption could be considered as a potential therapy against cancer
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.